PDX Pharmaceuticals, Inc.

New Filing
CIK: 0001795304·Biotechnology·OREGON·Filed: Nov 27, 2019
Total Offering

$4,049,923

Amount Sold

$1,550,000

Investors

2

First Sale

Nov 18, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Wassana Yantasee
Related Person
Worapol Ngamcherdtrakul
Related Person
Joe Gray
Related Person
Angela Hult
Related Person

Company

PDX Pharmaceuticals, Inc.

3303 SW BOND AVENUE, CH13B

PORTLAND, OR, 97239

503-418-9306

SEC Filing

0001795304-19-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
PDX Pharmaceuticals, Inc. Form D Filing — $4,049,923 | FilingFlow